Updated Jul 16, 2026
Garrison Michael David has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.60M.

Michael David Garrison is an executive at Becton Dickinson and Company, where he serves as Executive Vice President and President of Medical Essentials and BioPharmaceuticals. He has held various leadership roles within the company, focusing on medical products and services.
| Role | EVP & Pres Med.Essntl&BioPharm |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-25 | BDX | BECTON DICKINSON & CO | S — Open-market sale | 1.1K | $145.66 | $160K |
| 2026-06-11 | BDX | BECTON DICKINSON & CO | S — Open-market sale | 1.1K | $151.48 | $167K |
| 2026-01-16 | BDX | BECTON DICKINSON & CO | S — Open-market sale [10b5-1] | 1.0K | $206.54 | $209K |
| 2026-01-16 | BDX | BECTON DICKINSON & CO | S — Open-market sale [10b5-1] | 600 | $209.00 | $125K |
| 2026-01-16 | BDX | BECTON DICKINSON & CO | D — Derivative transaction [10b5-1] | 2.5K | $209.00 | $513K |
| 2026-01-16 | BDX | BECTON DICKINSON & CO | M — Option exercise [10b5-1] | 3.1K | $167.91 | $513K |
| 2025-07-18 | BDX | BECTON DICKINSON & CO | S — Open-market sale | 1 | $181.50 | $182 |
| 2025-07-18 | BDX | BECTON DICKINSON & CO | S — Open-market sale | 1.2K | $180.29 | $213K |
| 2025-07-18 | BDX | BECTON DICKINSON & CO | D — Derivative transaction | 5.2K | $180.29 | $933K |
| 2025-07-18 | BDX | BECTON DICKINSON & CO | M — Option exercise | 6.4K | $147.68 | $939K |
| 2025-04-09 | BDX | BECTON DICKINSON & CO | S — Open-market sale | 479 | $197.28 | $94K |
| 2024-12-20 | BDX | BECTON DICKINSON & CO | S — Open-market sale [10b5-1] | 2.8K | $223.33 | $634K |
| 2024-11-29 | BDX | BECTON DICKINSON & CO | F — Tax withholding / forfeiture | 1.2K | $0.00 | |
| 2024-11-29 | BDX | BECTON DICKINSON & CO | A — Grant or award | 2.3K | $0.00 | |
| 2024-11-29 | BDX | BECTON DICKINSON & CO | A — Grant or award | 2.6K | $0.00 |
Michael David Garrison is an executive at Becton Dickinson and Company, where he serves as Executive Vice President and President of Medical Essentials and BioPharmaceuticals. He has held various leadership roles within the company, focusing on medical products and services.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($1.60M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Garrison Michael David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.